XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Adoption of ASU No. 2016-13
Common stock and additional paid-in capital
Retained earnings
Retained earnings
Adoption of ASU No. 2016-13
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2022     11,045,186      
Balance at beginning of period at Dec. 31, 2022 $ 228,923 $ (6,277) $ 68,545 $ 204,343 $ (6,277) $ (43,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
     Net income 7,971     7,971    
Net unrealized gain (loss) on securities available for sale, net of tax 4,181         4,181
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 4         4
Net unrealized (loss) gain on hedging derivative instruments, net of tax (2,736)         (2,736)
Comprehensive income (loss) 9,420     7,971   1,449
Cash dividends declared (3,764)     (3,764)    
Equity compensation expense 184   $ 184      
Payment to repurchase common stock (in shares)     (11,824)      
Payment to repurchase common stock (237)     (237)    
Issuance of restricted stock (in shares)     33,610      
Proceeds from sale of common stock (in shares)     7,210      
Proceeds from sale of common stock $ 212   $ 212      
Ending balance (in shares) at Mar. 31, 2023 11,074,182   11,074,182      
Balance at end of period at Mar. 31, 2023 $ 228,461   $ 68,941 202,036   (42,516)
Beginning balance (in shares) at Dec. 31, 2023 11,098,057   11,098,057      
Balance at beginning of period at Dec. 31, 2023 $ 243,079   $ 70,182 211,925   (39,028)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
     Net income 6,021     6,021    
Net unrealized gain (loss) on securities available for sale, net of tax (3,241)         (3,241)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 2         2
Net unrealized (loss) gain on hedging derivative instruments, net of tax 435         435
Comprehensive income (loss) 3,217     6,021   (2,804)
Cash dividends declared (3,896)     (3,896)    
Equity compensation expense 231   $ 231      
Payment to repurchase common stock (in shares)     (8,031)      
Payment to repurchase common stock (211)     (211)    
Issuance of restricted stock (in shares)     32,859      
Proceeds from sale of common stock (in shares)     8,048      
Proceeds from sale of common stock $ 204   $ 204      
Ending balance (in shares) at Mar. 31, 2024 11,130,933   11,130,933      
Balance at end of period at Mar. 31, 2024 $ 242,624   $ 70,617 $ 213,839   $ (41,832)